论文部分内容阅读
目的: 观察低分子肝素 ( L M W H, 商品名速避凝) 治疗不稳定心绞痛 ( U A P) 的疗效。方法: 将46 例 U A P 患者分为2 组: 在常规治疗的基础上, A 组加用阿斯匹林; B 组加用 L M W H 及阿斯匹林, 连续7 d 。结果: A 组和 B 组7 d 内的心绞痛再发率、缓解率、急性心肌梗塞发生率及心性死亡的发生率分别为636 % 和25 % ( P < 001) 、545 % 和875 %( P< 005) 、91 % 和0 、45 % 和0 , 2 组均无出血发生。结论: L M W H 加阿斯匹林较单用阿斯匹林治疗 U A P 疗效更好。
Objective: To observe the effect of low molecular weight heparin (L M W H) on the treatment of unstable angina pectoris (UA P). Methods: 46 cases of UA P patients were divided into two groups: on the basis of conventional treatment, A group plus aspirin; B plus L M W H and aspirin for 7 days. Results: The recurrence rate, remission rate, incidence of acute myocardial infarction and the incidence of cardiac death in groups A and B within 7 days were 636% and 25% (P <001), 545 % And 875% (P <005). No bleeding occurred in 91%, 045% and 0, 2 groups. CONCLUSION: L M W H plus aspirin is more effective than aspirin alone in the treatment of UA P.